France Blood Glucose Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

France Blood Glucose Monitoring Market is segmented into Type (Self-monitoring Blood Glucose and Continuous Glucose Monitoring), Component (Glucometer Devices, Test Strips, Lancets, Sensors, and Durables). The report offers the value (in USD million) and volume (in Units million) for the above segments.

France Blood Glucose Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

France Blood Glucose Monitoring Market Size

View Global Report
France Blood Glucose Monitoring Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
Market Size (2025) USD 0.94 Billion
Market Size (2030) USD 1.42 Billion
CAGR (2025 - 2030) 8.50 %

Major Players

France Blood Glucose Monitoring Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of France Blood Glucose Monitoring Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

France Blood Glucose Monitoring Market Analysis

The France Blood Glucose Monitoring Market size is estimated at USD 0.94 billion in 2025, and is expected to reach USD 1.42 billion by 2030, at a CAGR of 8.5% during the forecast period (2025-2030).

One of the most significant risk factors for a severe course of COVID-19 is diabetes mellitus. This risk is believed to be influenced by several variables that are frequently present in diabetes mellitus, such as advanced age, a proinflammatory and hypercoagulable condition, hyperglycemia, and underlying comorbidities (hypertension, cardiovascular disease, chronic kidney disease, and obesity). Diabetes was quickly recognized as a risk factor for bad results during the coronavirus disease-2019 (COVID-19) pandemic epidemic. Diabetes has previously been identified as a significant risk factor for death in individuals infected with either the Middle East respiratory syndrome-related coronavirus (MERS-CoV) or the 2009 H1N1 pandemic influenza. More recently, one of the main comorbidities linked to COVID-19 has consistently been diabetes.

Diabetes has the highest prevalence among all chronic conditions covered 100% by France's statutory health insurance (SHI), and the number of covered patients has doubled in the past 10 years. France is one of the major countries in the Europe region. According to the World Health Organization (WHO), about a million are diagnosed with diabetes in France. The prevalence of diabetes is growing among all ages in France, which can be attributed to the growing obese population, along with unhealthy diets and sedentary lifestyles of people. Furthermore, approximately 0.26 million are estimated to live with Type 1 diabetes in the region. Thus, the rising prevalence of diabetes and obesity, growing awareness, regarding diabetic care, healthcare expenditure, and technological advancements are a few factors that are further driving the market for diabetes care devices in France. In France, there is a centralized health care system their all the reimbursement decisions are taken at a national level and then applies to all of the countries. For diabetes technological devices in France, the reimbursement is based on the tariff system.

Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period.

France Blood Glucose Monitoring Industry Overview

The France blood glucose monitoring market is highly fragmented, with few major manufacturers present in the market. The CGM devices market is dominated by major players like Dexcom, Medtronic, Abbott, and Senseonics. The market for BGM devices comprises more generic players like Roche, LifeScan, Arkray, Ascensia, etc. Technological innovations in the recent past helped companies to strengthen their market presence.

France Blood Glucose Monitoring Market Leaders

  1. Roche

  2. Abbott

  3. Medtronics

  4. LifeScan

  5. Dexcom

  6. *Disclaimer: Major Players sorted in no particular order
France Blood Glucose Monitoring Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

France Blood Glucose Monitoring Market News

  • March 2022: Dexcom announced the receipt of a CE Mark for its G7 CGM system in Europe, intended for people who have diabetes and are two years and older, including pregnant women. With this approval, the highly popular and best-selling real-time CGM in the world is now more powerful and easier to use with a small, all-in-one wearable and completely redesigned mobile app.
  • January 2022: Roche launched its new point-of-care blood glucose monitor designed for hospital professionals, with a companion device shaped like a touchscreen smartphone that will run its apps. The hand-held Cobas pulse includes an automated glucose test strip reader as well as a camera and touchscreen for logging other diagnostic results. It's designed to be used with patients of all ages, including neonates and people in intensive care.

France Blood Glucose Monitoring Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Drivers
  • 4.3 Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Self-monitoring Blood Glucose Devices
    • 5.1.1 Glucometer Devices
    • 5.1.2 Test Strips
    • 5.1.3 Lancets
  • 5.2 Continuous Blood Glucose Monitoring Devices
    • 5.2.1 Sensors
    • 5.2.2 Durables (Receivers and Transmitters)

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes population
  • 6.2 Type-2 Diabetes population

7. COMPETITIVE LANDSCAPE

  • 7.1 COMPANY PROFILES
    • 7.1.1 Abbott Diabetes Care
    • 7.1.2 Roche Holding AG
    • 7.1.3 LifeScan
    • 7.1.4 Dexcom Inc.
    • 7.1.5 Medtronic PLC
    • 7.1.6 Arkray Inc.
    • 7.1.7 Ascensia Diabetes Care
    • 7.1.8 Agamatrix Inc.
    • 7.1.9 Bionime Corporation
    • 7.1.10 Acon Laboratories Inc.
    • 7.1.11 Trivida Functional Medicine
    • 7.1.12 Senseonics
  • *List Not Exhaustive
  • 7.2 COMPANY SHARE ANALYSIS
    • 7.2.1 Self-monitoring Blood Glucose Devices
    • 7.2.1.1 Abbott Diabetes Care
    • 7.2.1.2 Roche Holding AG
    • 7.2.1.3 LifeScan
    • 7.2.2 Continuous Glucose Monitoring Devices
    • 7.2.2.1 Dexcom Inc.
    • 7.2.2.2 Medtronic PLC
    • 7.2.2.3 Abbott Diabetes Care

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

France Blood Glucose Monitoring Industry Segmentation

Blood Glucose Monitoring Devices are used to diagnose both hyperglycemic and hypoglycemic conditions in diabetic patients. France Blood Glucose Monitoring Market is segmented into Type (Self-monitoring Blood Glucose and Continuous Glucose Monitoring), Component (Glucometer Devices, Test Strips, Lancets, Sensors, and Durables). The report offers the value (in USD million) and volume (in Units million) for the above segments.

Self-monitoring Blood Glucose Devices Glucometer Devices
Test Strips
Lancets
Continuous Blood Glucose Monitoring Devices Sensors
Durables (Receivers and Transmitters)
Need A Different Region or Segment?
Customize Now

France Blood Glucose Monitoring Market Research FAQs

How big is the France Blood Glucose Monitoring Market?

The France Blood Glucose Monitoring Market size is expected to reach USD 0.94 billion in 2025 and grow at a CAGR of 8.5% to reach USD 1.42 billion by 2030.

What is the current France Blood Glucose Monitoring Market size?

In 2025, the France Blood Glucose Monitoring Market size is expected to reach USD 0.94 billion.

Who are the key players in France Blood Glucose Monitoring Market?

Roche, Abbott, Medtronics, LifeScan and Dexcom are the major companies operating in the France Blood Glucose Monitoring Market.

What years does this France Blood Glucose Monitoring Market cover, and what was the market size in 2024?

In 2024, the France Blood Glucose Monitoring Market size was estimated at USD 0.86 billion. The report covers the France Blood Glucose Monitoring Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the France Blood Glucose Monitoring Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

France Blood Glucose Monitoring Industry Report

Statistics for the 2025 France Blood Glucose Monitoring market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. France Blood Glucose Monitoring analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.